Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.00-1.54%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.50M | 5.67M | 6.12M | 7.50M | 7.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.35M | 8.28M | 15.44M | 19.35M | 25.36M |
| Operating Income | -4.35M | -8.28M | -15.44M | -19.35M | -25.36M |
| Income Before Tax | -9.17M | -13.56M | -16.44M | -16.16M | -26.08M |
| Income Tax Expenses | 0.00 | 0.00 | 0.00 | -2.97M | -3.38M |
| Earnings from Continuing Operations | -9.17 | -13.56 | -16.44 | -13.19 | -22.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.17M | -13.56M | -16.44M | -13.19M | -22.70M |
| EBIT | -4.35M | -8.28M | -15.44M | -19.35M | -25.36M |
| EBITDA | -4.33M | -8.27M | -15.44M | -19.32M | -25.32M |
| EPS Basic | -13.39 | -49.56 | -83.31 | -109.29 | -223.67 |
| Normalized Basic EPS | -12.14 | -35.06 | -80.54 | -128.02 | -167.48 |
| EPS Diluted | -13.39 | -49.56 | -83.31 | -109.29 | -223.67 |
| Normalized Diluted EPS | -12.14 | -35.06 | -80.54 | -128.02 | -167.48 |
| Average Basic Shares Outstanding | 25.92M | 14.44M | 3.23M | 491.20K | 440.00K |
| Average Diluted Shares Outstanding | 25.92M | 14.44M | 3.23M | 491.20K | 440.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |